$11.42
-0.07-0.61%
Last update: 1:37 PM
15 minutes delayed
Comments
Loading...
Viatris (VTRS) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestViatris (NASDAQ:VTRS) Stock Quotes, Forecast and News Summary
Viatris Stock (NASDAQ: VTRS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Viatris (VTRS) stock?
You can purchase shares of Viatris (NASDAQ:VTRS) through any online brokerage.
Who are Viatris (VTRS) competitors?
Other companies in Viatris’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
What is the forecast, or price target, for Viatris (VTRS) stock?
Viatris has a consensus price target of $12.22.
What is the current price for Viatris (VTRS)?
The stock price for Viatris (NASDAQ: VTRS) is $11.49 last updated October 2, 2024 at 9:30 AM EDT.
Does Viatris (VTRS) pay a dividend?
A quarterly cash dividend of 0.12 per share of Class A Common Stock. The quarterly cash dividend was payable on September 13, 2024 to stockholders of record on August 23, 2024.
When is Viatris (NASDAQ:VTRS) reporting earnings?
Viatris’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Viatris (VTRS) going to split?
There is no upcoming split for Viatris.
What sector and industry does Viatris (VTRS) operate in?
Viatris is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.